Combined drug treatment of tuberculosis. I. Prevention of emergence of mutant populations of tubercle bacilli resistant to both streptomycin and isoniazid in vitro.
D001407:Bacillus; D035843:Biomedical Research; D006094:Gram-Positive Bacteria; D006801:Humans; D066298:In Vitro Techniques; D007538:Isoniazid / Q000494:pharmacology*; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D013307:Streptomycin / Q000494:pharmacology*; D014376:Tuberculosis
D007538:Isoniazid; D013307:Streptomycin
ISONIAZID/effects; MYCOBACTERIUM TUBERCULOSIS/effect of drugs on; STREPTOMYCIN/effects